5 Einträge gefunden

1. Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma

   1. Zech, Henrike B
   2. Moeckelmann, Nikolaus
   3. Boettcher, Arne
   4. Muenscher, Adrian
   5. Binder, Mascha
   6. Vettorazzi, Eik
   7. Bokemeyer, Carsten

   2020 - Forschungsinformationssystem des UKE
2. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

   1. Stamm, Hauke
   2. Klingler, Felix
   3. Grossjohann, Eva-Maria
   4. Muschhammer, Jana
   5. Vettorazzi, Eik
   6. Heuser, Michael
   7. Mock, Ulrike

   2018 - Forschungsinformationssystem des UKE
3. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples

   1. Murga-Penas, Eva-Maria
   2. Schilling, Georgia
   3. Behrmann, Petra
   4. Klokow, Marianne
   5. Vettorazzi, Eik
   6. Bokemeyer, Carsten
   7. Dierlamm, Judith

   2014 - Forschungsinformationssystem des UKE
4. Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significance

   1. Flammiger, Anna
   2. Bacher, Ulrike
   3. Christopeit, Maximilian
   4. Horn, Christiane
   5. Rühlmann, Elke
   6. Kluge, Katrin
   7. Vettorazzi, Eik

   2014 - Forschungsinformationssystem des UKE
5. Actual and predicted survival time of patients with spinal metastases of lung cancer: evaluation of the robustness of the Tokuhashi score.

   1. Hessler, Christian
   2. Vettorazzi, Eik
   3. Madert, Juergen
   4. Bokemeyer, Carsten
   5. Panse, Jens

   2011 - Forschungsinformationssystem des UKE